🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Improving Safety and Accuracy of Stereotactic Brain Biopsies in Primary Central Nervous System Lymphoma.

Recruitingn/aAges 18 Years - anyAllIRCCS San Raffaele
NCT06263361 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Primary central nervous system lymphoma (PCNSL) is an aggressive extranodal non- Hodgkin lymphoma exclusively localized into the nervous system. The aim of this study is to evaluate the MRI imaging characteristics of the peritumoral area (PTA) and to correlate this information to pathological findings.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult patients, undergoing stereotactic biopsy for newly diagnosed PSNCLs Exclusion Criteria: * Severe hepatic dysfunction * Severe renal dysfunction * Severe heart failure * myocardial infarction and stroke within 90 days * Hyperreactivity against contrast agents * Pregnancy
💊

What it tests

  • MRI imaging
  • Cerebral biopsy
📍

Where

1 site
IRCCS San Raffaele Scientific Institute
Milan, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy